Lydia Glaw, PhD

Assistant Director
US FDA

Lydia Glaw is an Assistant Director in the Office of Cardiovascular Devices at FDA. She supervises the Coronary Interventional Devices Team, which reviews all US regulatory submissions relating to coronary stents, catheters and guidewires.

Presentation(s):

• FDA Perspectives on Periprocedural MI in Trials Intended for Regulatory Review

  Tuesday, February 28, 2023
  11:25 AM – 11:33 AM ET

  Disclosure(s): AstraZeneca Pharmaceuticals: Employee (Ongoing), Salary (Ongoing)

• Panel Discussion: Defining Peri-Procedural MI in Clinical Trials

  Tuesday, February 28, 2023
  11:41 AM – 12:05 PM ET

  Disclosure(s): AstraZeneca Pharmaceuticals: Employee (Ongoing), Salary (Ongoing)